Cargando…

Poor communication between ER and mitochondria: a signature of ALS/FTD?

Detalles Bibliográficos
Autores principales:	Miller, Christopher C.J., Gomez-Suaga, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637802/ https://www.ncbi.nlm.nih.gov/pubmed/37870566 http://dx.doi.org/10.18632/aging.205206

Ejemplares similares

ALS/FTD‐associated FUS activates GSK‐3β to disrupt the VAPB–PTPIP51 interaction and ER–mitochondria associations
por: Stoica, Radu, et al.
Publicado: (2016)

ER-mitochondria signaling regulates autophagy
por: Gomez-Suaga, Patricia, et al.
Publicado: (2017)

The ER-Mitochondria Tethering Complex VAPB-PTPIP51 Regulates Autophagy
por: Gomez-Suaga, Patricia, et al.
Publicado: (2017)

There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
por: Paillusson, Sebastien, et al.
Publicado: (2016)

ER–mitochondria associations are regulated by the VAPB–PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43
por: Stoica, Radu, et al.
Publicado: (2014)

ER–mitochondria signaling in Parkinson’s disease
por: Gómez-Suaga, Patricia, et al.
Publicado: (2018)

Disruption of the VAPB-PTPIP51 ER-mitochondria tethering proteins in post-mortem human amyotrophic lateral sclerosis
por: Hartopp, Naomi, et al.
Publicado: (2022)

Examining the language and behavioural profile in FTD and ALS-FTD
por: Saxon, Jennifer A, et al.
Publicado: (2017)

Disruption of ER−mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis
por: Lau, Dawn H. W., et al.
Publicado: (2018)

α-Synuclein binds to the ER–mitochondria tethering protein VAPB to disrupt Ca(2+) homeostasis and mitochondrial ATP production
por: Paillusson, Sébastien, et al.
Publicado: (2017)

Inflammation in ALS/FTD pathogenesis
por: McCauley, Madelyn E., et al.
Publicado: (2018)

Genetic screening in sporadic ALS and FTD
por: Turner, Martin R, et al.
Publicado: (2017)

ALS/FTD-associated mutation in cyclin F inhibits ER-Golgi trafficking, inducing ER stress, ERAD and Golgi fragmentation
por: Ragagnin, Audrey M. G., et al.
Publicado: (2023)

Disruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer's disease brain
por: Lau, Dawn H.W., et al.
Publicado: (2020)

Motor Neuron Susceptibility in ALS/FTD
por: Ragagnin, Audrey M. G., et al.
Publicado: (2019)

Disruption of ER‐mitochondria tethering and signalling in C9orf72‐associated amyotrophic lateral sclerosis and frontotemporal dementia
por: Gomez‐Suaga, Patricia, et al.
Publicado: (2022)

The era of cryptic exons: implications for ALS-FTD
por: Mehta, Puja R., et al.
Publicado: (2023)

ER-Mitochondria Communication in Cells of the Innate Immune System
por: Namgaladze, Dmitry, et al.
Publicado: (2019)

The association between lifelong personality and clinical phenotype in the FTD-ALS spectrum
por: Vinceti, Giulia, et al.
Publicado: (2023)

Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
por: Godoy-Corchuelo, Juan Miguel, et al.
Publicado: (2022)

Neural circuit and synaptic dysfunctions in ALS-FTD pathology
por: Mora, Santiago, et al.
Publicado: (2023)

Cognitive and behavioral features of c9FTD/ALS
por: Boeve, Bradley F, et al.
Publicado: (2012)

Linking hnRNP Function to ALS and FTD Pathology
por: Purice, Maria D., et al.
Publicado: (2018)

ALS/FTD: Evolution, Aging, and Cellular Metabolic Exhaustion
por: Henderson, Robert David, et al.
Publicado: (2022)

Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress
por: Zhang, Yong-Jie, et al.
Publicado: (2014)

A gene signature of loss of oestrogen receptor (ER) function and oxidative stress links ER-positive breast tumours with an absent progesterone receptor and a poor prognosis
por: Neven, Patrick, et al.
Publicado: (2008)

Novel function of the tumor suppressor PML at ER-mitochondria sites in the control of autophagy
por: Missiroli, Sonia, et al.
Publicado: (2017)

Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD
por: Mayl, Keith, et al.
Publicado: (2021)

Clinical and neuropathological features of ALS/FTD with TIA1 mutations
por: Hirsch-Reinshagen, Veronica, et al.
Publicado: (2017)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
por: Hedl, Thomas J., et al.
Publicado: (2019)

Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci
por: He, Fang, et al.
Publicado: (2016)

Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS‐FTD spectrum
por: Devenney, Emma M., et al.
Publicado: (2021)

ER stress links aging to sporadic ALS
por: Medinas, Danilo B., et al.
Publicado: (2019)

ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad
por: Kaus, Anjoscha, et al.
Publicado: (2015)

PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in C9ORF72-ALS/FTD
por: Pilotto, Federica, et al.
Publicado: (2022)

An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD
por: Bauer, Claudia S., et al.
Publicado: (2022)

The aging of ER-mitochondria communication: A journey from undifferentiated to aged cells
por: Morgado-Cáceres, Pablo, et al.
Publicado: (2022)

Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Pathogenesis of FUS-associated ALS and FTD: insights from rodent models
por: Nolan, Matthew, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o2kuuhioneemkk0pctq6f0tf8e